1. Home
  2. Labeler Index
  3. Sagent Pharmaceuticals
  4. 25021-183
  5. NDC Package Code: 25021-183-67 Cefuroxime Sodium

NDC Package 25021-183-67 Cefuroxime Sodium

Injection, Powder, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
25021-183-67
Package Description:
25 VIAL in 1 CARTON / 16 mL in 1 VIAL
Product Code:
25021-183
Proprietary Name:
Cefuroxime Sodium
Non-Proprietary Name:
Cefuroxime Sodium
Substance Name:
Cefuroxime Sodium
Usage Information:
Cefuroxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.
11-Digit NDC Billing Format:
25021018367
NDC to RxNorm Crosswalk:
  • RxCUI: 1665444 - cefuroxime 1.5 GM Injection
  • RxCUI: 1665444 - cefuroxime 1500 MG Injection
  • RxCUI: 1665449 - cefuroxime 750 MG Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sagent Pharmaceuticals
    Dosage Form:
    Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • CEFUROXIME SODIUM 1.5 g/16mL
    • Pharmacologic Class(es):
  • Cephalosporin Antibacterial - [EPC] (Established Pharmacologic Class)
  • Cephalosporins - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA064125
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-01-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 25021-183-67?

    The NDC Packaged Code 25021-183-67 is assigned to a package of 25 vial in 1 carton / 16 ml in 1 vial of Cefuroxime Sodium, a human prescription drug labeled by Sagent Pharmaceuticals. The product's dosage form is injection, powder, for solution and is administered via intravenous form.

    Is NDC 25021-183 included in the NDC Directory?

    Yes, Cefuroxime Sodium with product code 25021-183 is active and included in the NDC Directory. The product was first marketed by Sagent Pharmaceuticals on September 01, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 25021-183-67?

    The 11-digit format is 25021018367. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-225021-183-675-4-225021-0183-67